A Systems Biology Approach for Hypothesizing the Effect of Genetic Variants on Neuroimaging Features in Alzheimer’s Disease
暂无分享,去创建一个
Charles Tapley Hoyt | Sepehr Golriz Khatami | M. Hofmann-Apitius | S. Mubeen | Reagon Karki | C. Robinson | A. Kodamullil | D. Domingo-Fernándéz | Anandhi Iyappan | S. G. Khatami
[1] G. Cenini,et al. Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update , 2019, Front. Pharmacol..
[2] Mohammad Asif Emon,et al. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures , 2019, BMC Bioinformatics.
[3] Andreas Spiegler,et al. Linking Molecular Pathways and Large-Scale Computational Modeling to Assess Candidate Disease Mechanisms and Pharmacodynamics in Alzheimer's Disease , 2019, bioRxiv.
[4] C. Wahlestedt,et al. HDAC Inhibitors Induce BDNF Expression and Promote Neurite Outgrowth in Human Neural Progenitor Cells-Derived Neurons , 2019, International journal of molecular sciences.
[5] Andrew J. Saykin,et al. A Longitudinal Imaging Genetics Study of Neuroanatomical Asymmetry in Alzheimer’s Disease , 2018, Biological Psychiatry.
[6] Aron K Barbey,et al. Small sample sizes reduce the replicability of task-based fMRI studies , 2018, Communications Biology.
[7] Sorin Draghici,et al. A novel computational approach for drug repurposing using systems biology , 2018, Bioinform..
[8] I. Scheffer,et al. KANSL1 variation is not a major contributing factor in self-limited focal epilepsy syndromes of childhood , 2018, PloS one.
[9] Thawfeek M. Varusai,et al. The Reactome Pathway Knowledgebase , 2017, Nucleic Acids Res..
[10] Ryan Miller,et al. WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research , 2017, Nucleic Acids Res..
[11] N. Greig,et al. Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview. , 2017, Current Alzheimer research.
[12] Charles Tapley Hoyt,et al. PyBEL: a computational framework for Biological Expression Language , 2017, Bioinform..
[13] Martin Hofmann-Apitius,et al. Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features , 2017, Journal of Alzheimer's disease : JAD.
[14] S. Rankin,et al. Evidence of Oxidative Stress and Secondary Mitochondrial Dysfunction in Metabolic and Non-Metabolic Disorders , 2017, Journal of clinical medicine.
[15] Mohammad Asif Emon,et al. Multimodal mechanistic signatures for neurodegenerative diseases (NeuroMMSig): a web server for mechanism enrichment , 2017, Bioinform..
[16] B. Kaang,et al. Epigenetic regulation and chromatin remodeling in learning and memory , 2017, Experimental & Molecular Medicine.
[17] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[18] Marie-Thérèse Heemels,et al. Neurodegenerative diseases , 2016, Nature.
[19] O. Kretz,et al. MOF Acetyl Transferase Regulates Transcription and Respiration in Mitochondria , 2016, Cell.
[20] Núria Queralt-Rosinach,et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..
[21] Peter Veselcic,et al. Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology , 2016, Neurobiology of Disease.
[22] D. Hanger,et al. Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons , 2016, Neurobiology of Disease.
[23] Desheng Wang,et al. Dietary cholesterol concentration affects synaptic plasticity and dendrite spine morphology of rabbit hippocampal neurons , 2015, Brain Research.
[24] M. Moreno-Igoa,et al. KANSL1 gene disruption associated with the full clinical spectrum of 17q21.31 microdeletion syndrome , 2015, BMC Medical Genetics.
[25] Magda Tsolaki,et al. A NOVEL ALZHEIMER DISEASE LOCUS LOCATED NEAR THE GENE ENCODING TAU PROTEIN , 2015, Molecular Psychiatry.
[26] A. Fischer,et al. Histone-acetylation: a link between Alzheimer's disease and post-traumatic stress disorder? , 2014, Front. Neurosci..
[27] H. Ostrer,et al. Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes. , 2014, Human molecular genetics.
[28] Ted Slater,et al. Recent advances in modeling languages for pathway maps and computable biological networks. , 2014, Drug discovery today.
[29] M. Nöthen,et al. Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene , 2014, Translational Psychiatry.
[30] Elke Edelmann,et al. Pre- and postsynaptic twists in BDNF secretion and action in synaptic plasticity , 2014, Neuropharmacology.
[31] F. Catalá-López,et al. Alzheimer's Disease and Cancer: Current Epidemiological Evidence for a Mutual Protection , 2014, Neuroepidemiology.
[32] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[33] Z. Fišar,et al. Control mechanisms in mitochondrial oxidative phosphorylation☆ , 2013, Neural regeneration research.
[34] J. Moscat,et al. TRAF6 and p62 inhibit amyloid β-induced neuronal death through p75 neurotrophin receptor , 2012, Neurochemistry International.
[35] Sang Hong Lee,et al. Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood , 2012, Bioinform..
[36] Eurie L. Hong,et al. Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.
[37] S. Bhatta,et al. Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer’s disease , 2012, Experimental Brain Research.
[38] P. Scheltens,et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[39] M. Lei,et al. Structural insight into the regulation of MOF in the male-specific lethal complex and the non-specific lethal complex , 2012, Cell Research.
[40] T. A. Rosenberger,et al. Acetate supplementation modulates brain histone acetylation and decreases interleukin-1β expression in a rat model of neuroinflammation , 2012, Journal of Neuroinflammation.
[41] Chuong B. Do,et al. Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database , 2012, PLoS genetics.
[42] Jo Knight,et al. Introduction to genetic association studies. , 2012, Cold Spring Harbor protocols.
[43] Manolis Kellis,et al. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..
[44] Paul M. Thompson,et al. Neuroimaging Measures as Endophenotypes in Alzheimer's Disease , 2011, International journal of Alzheimer's disease.
[45] R. Desikan,et al. Genetic variation and neuroimaging measures in Alzheimer disease. , 2010, Archives of neurology.
[46] Fatima Soliman,et al. Imaging genetics and development: Challenges and promises , 2010, Human brain mapping.
[47] Joseph V. Hajnal,et al. A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T) , 2010, NeuroImage.
[48] M. Costanzi,et al. Impaired Terminal Differentiation of Hippocampal Granule Neurons and Defective Contextual Memory in PC3/Tis21 Knockout Mice , 2009, PloS one.
[49] M. Cole,et al. Subunit Composition and Substrate Specificity of a MOF-containing Histone Acetyltransferase Distinct from the Male-specific Lethal (MSL) Complex* , 2009, The Journal of Biological Chemistry.
[50] A. Simmons,et al. AddNeuroMed—The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease , 2009, Annals of the New York Academy of Sciences.
[51] A. Hill,et al. ATP‐binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro , 2008, Journal of neurochemistry.
[52] F. Tagliavini,et al. A new function of microtubule-associated protein tau: Involvement in chromosome stability , 2008, Cell cycle.
[53] Andreas Meyer-Lindenberg,et al. False positives in imaging genetics , 2008, NeuroImage.
[54] Hongyu Luo,et al. Tissue-specific expression of B-cell translocation gene 2 (BTG2) and its function in T-cell immune responses in a transgenic mouse model. , 2008, International immunology.
[55] Jose C Florez,et al. Introduction to genetic association studies. , 2007, The Journal of investigative dermatology.
[56] A. Levey,et al. Evidence of shared risk for Alzheimer’s disease and Parkinson’s disease using family history , 2007, Neurogenetics.
[57] Rachael L Neve,et al. The cell cycle as a therapeutic target for Alzheimer's disease. , 2006, Pharmacology & therapeutics.
[58] Mu-ming Poo,et al. Shrinkage of Dendritic Spines Associated with Long-Term Depression of Hippocampal Synapses , 2004, Neuron.
[59] Hongye Li,et al. Genetic Bottlenecks Reduce Population Variation in an Experimental RNA Virus Population , 2004, Journal of Virology.
[60] M. Bear,et al. LTP and LTD An Embarrassment of Riches , 2004, Neuron.
[61] M. Mattson,et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[62] A. Koudinov,et al. Cholesterol, synaptic function and Alzheimer's disease. , 2003, Pharmacopsychiatry.
[63] R. Nussbaum,et al. Alzheimer's disease and Parkinson's disease. , 2003, The New England journal of medicine.
[64] P. Gregory,et al. Histone acetylation and chromatin remodeling. , 2001, Experimental cell research.
[65] J. Magaud,et al. Interaction of BTG1 and p53-regulatedBTG2 Gene Products with mCaf1, the Murine Homolog of a Component of the Yeast CCR4 Transcriptional Regulatory Complex* , 1998, The Journal of Biological Chemistry.
[66] R. Weichselbaum,et al. p53 Expression Induces Apoptosis in Hippocampal Pyramidal Neuron Cultures , 1997, The Journal of Neuroscience.
[67] R. Berger,et al. Identification of BTG2, an antiproliferative p53–dependent component of the DNA damage cellular response pathway , 1996, Nature Genetics.
[68] A. Rajput,et al. Alzheimer's Disease and Idiopathic Parkinson's Disease Coexistence , 1993, Journal of geriatric psychiatry and neurology.
[69] A. Boyle,et al. Human Mutation , 2019 .
[70] C. Bramham,et al. BDNF and Hippocampal Synaptic Plasticity. , 2017, Vitamins and hormones.
[71] Dana C. Crawford,et al. The detection and characterization of pleiotropy: discovery, progress, and promise , 2016, Briefings Bioinform..
[72] T. Abel,et al. The Role of Histone Acetylation in Memory Formation and Cognitive Impairments , 2013, Neuropsychopharmacology.
[73] M. Mattson,et al. Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders , 2002, NeuroMolecular Medicine.